The results indicate that pycnogenol supplementation improves levels of HDL-C ; however , the changes in TC , TAG , and LDL-C were not clinical ly relevant .
Since there are few phytochemicals that have a significant increasing effect on HDL-C levels  , pycnogenol may have important role in prevention of cardiovascular diseases
The effects of pycnogenol on plasma lipids are controversial .
A systematic review and meta- analysis of clinical trials were conducted to obtain a conclusive result in humans .
Improvement of Diabetic Microangiopathy With Pycnogenol®: A Prospective, Controlled Study
The aim of this study was to investigate the clinical efficacy of oral Pycnogenol ® ( Horphag Research Ltd , United Kingdom ) in patients with diabetic microangiopathy . Patients without a history of diabetic ulcerations were treated with Pycnogenol . Patients received oral Pycnogenol ( 50 mg capsules , 3 times daily for a total of 150 mg daily for 4 weeks ) . A group of 30 patients was included ( severe microangiopathy ) ; 30 comparable patients were observed as controls ( no treatment during the observation period ) . All patients ( age , 59 years ; range , 55 - 68 years ; male : female = 18:12 ) included in the treatment group completed the 4-week study . Also , all controls completed the follow-up period . There were no drop-outs . All included subjects had signs and symptoms of diabetic microangiopathy . The duration of diabetes — from the first signs/symptoms — was on average 7.5 years ( SD = 3 ) . After 4 weeks , microcirculatory and clinical evaluations showed a progressive decrease in skin flux at rest in the foot ( indicating an improvement in the level of microangiopathy ) , a significant decrease in capillary filtration , and a significant improvement in the venoarteriolar response in all treated subjects . There were no visible effects in controls except a slight reduction in skin flux at rest in the foot . Treatment was well tolerated in both groups . In conclusion , this study confirms the clinical efficacy of Pycnogenol in patients with diabetic microangiopathy . The study indicates the clinical role of Pycnogenol in the management , treatment , and control of this common clinical problem . The treatment may be also useful to prevent diabetic ulcerations by controlling the level of microangiopathy
The results indicate that pycnogenol supplementation improves levels of HDL-C ; however , the changes in TC , TAG , and LDL-C were not clinical ly relevant .
Since there are few phytochemicals that have a significant increasing effect on HDL-C levels  , pycnogenol may have important role in prevention of cardiovascular diseases
The effects of pycnogenol on plasma lipids are controversial .
A systematic review and meta- analysis of clinical trials were conducted to obtain a conclusive result in humans .